Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02703272 |
| Title | A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Janssen Research & Development, LLC |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA | TUR | SWE | ROU | POL | NLD | HUN | GBR | FRA | ESP | DEU | CZE | CAN | BRA | BGR | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Los Angeles | California | United States | Details | |||
| Orange | California | United States | Details | |||
| Palo Alto | California | United States | Details | |||
| Aurora | Colorado | United States | Details | |||
| Washington D.C. | District of Columbia | United States | Details | |||
| Atlanta | Georgia | United States | Details | |||
| Baltimore | Maryland | United States | Details | |||
| Boston | Massachusetts | United States | Details | |||
| New York | New York | United States | Details | |||
| Valhalla | New York | United States | Details | |||
| Charlotte | North Carolina | United States | Details | |||
| Cincinnati | Ohio | United States | Details | |||
| Columbus | Ohio | United States | Details | |||
| Philadelphia | Pennsylvania | United States | Details | |||
| Dallas | Texas | United States | Details | |||
| Salt Lake City | Utah | United States | Details | |||
| Milwaukee | Wisconsin | United States | Details | |||
| Brussels | Belgium | Details | ||||
| Leuven | Belgium | Details | ||||
| Barretos | Brazil | Details | ||||
| Curitiba | Brazil | Details | ||||
| São Paulo | Brazil | Details | ||||
| Plovdiv | Bulgaria | Details | ||||
| Sofia | Bulgaria | Details | ||||
| Halifax | Nova Scotia | Canada | Details | |||
| Toronto | Ontario | Canada | Details | |||
| Brno | Czechia | Details | ||||
| Prague | Czechia | Details | ||||
| Bordeaux | France | Details | ||||
| Lille | France | Details | ||||
| Lyon | France | Details | ||||
| Marseille | France | Details | ||||
| Nantes | France | Details | ||||
| Toulouse | France | Details | ||||
| Vandœuvre-lès-Nancy | France | Details | ||||
| Villejuif | France | Details | ||||
| Berlin | Germany | Details | ||||
| Freiburg im Breisgau | Germany | Details | ||||
| Kiel | Germany | Details | ||||
| München | Germany | Details | ||||
| Münster | Germany | Details | ||||
| Budapest | Hungary | Details | ||||
| Debrecen | Hungary | Details | ||||
| Rotterdam | Netherlands | Details | ||||
| Utrecht | Netherlands | Details | ||||
| Krakow | Poland | Details | ||||
| Warsaw | Poland | Details | ||||
| Wroclaw | Poland | Details | ||||
| Bucharest | Romania | Details | ||||
| Cluj-Napoca | Romania | Details | ||||
| Oradea | Romania | Details | ||||
| Timișoara | Romania | Details | ||||
| Moscow | Russia | Details | ||||
| Saint Petersburg | Russia | Details | ||||
| Yekaterinburg | Russia | Details | ||||
| Seoul | South Korea | Details | ||||
| Barcelona | Spain | Details | ||||
| Esplugues de Llobregat | Spain | Details | ||||
| Madrid | Spain | Details | ||||
| Valencia | Spain | Details | ||||
| Gothenburg | Sweden | Details | ||||
| Kaohsiung City | Taiwan | Details | ||||
| Taipei | Taiwan | Details | ||||
| Taoyuan District | Taiwan | Details | ||||
| Ankara | Turkey (Türkiye) | Details | ||||
| Izmir | Turkey (Türkiye) | Details | ||||
| Kiev | Ukraine | Details | ||||
| Birmingham | United Kingdom | Details | ||||
| Cambridge | United Kingdom | Details | ||||
| Leeds | United Kingdom | Details | ||||
| Liverpool | United Kingdom | Details | ||||
| London | United Kingdom | Details | ||||
| Manchester | United Kingdom | Details | ||||
| Newcastle | United Kingdom | Details | ||||
| Sheffield | United Kingdom | Details | ||||
| Surrey | United Kingdom | Details |